InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: A deleted message

Friday, 12/02/2016 1:15:11 PM

Friday, December 02, 2016 1:15:11 PM

Post# of 345786
Dr Wolchok loves PS Targeting and all IO effectors have all to do with Peregrine Pharmaceuticals. I know this for a fact....Dr Wolchok about to send PS Targeting into the BPs pipelines

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News